These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1403 related items for PubMed ID: 9436955

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD.
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [Abstract] [Full Text] [Related]

  • 23. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G, Carricajo A.
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Jul; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 27. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Jul; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, Vogelaers DP, Decruyenaere JM, Colardyn FA.
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [Abstract] [Full Text] [Related]

  • 29. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
    Wenisch C.
    Wien Med Wochenschr; 2000 Mar; 150(3):37-41. PubMed ID: 10756595
    [Abstract] [Full Text] [Related]

  • 30. Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.
    Goss TF, Forrest A, Nix DE, Ballow CH, Birmingham MC, Cumbo TJ, Schentag JJ.
    Ann Pharmacother; 1994 Mar; 28(7-8):863-8. PubMed ID: 7949501
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA, Sanchez Bruni SF, Jones DG.
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [Abstract] [Full Text] [Related]

  • 32. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA.
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [Abstract] [Full Text] [Related]

  • 33. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.
    Schentag JJ, Meagher AK, Forrest A.
    Ann Pharmacother; 2003 Oct; 37(10):1478-88. PubMed ID: 14519053
    [Abstract] [Full Text] [Related]

  • 34. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
    Kollef MH.
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S131-8. PubMed ID: 11017862
    [Abstract] [Full Text] [Related]

  • 35. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
    Cousson J, Floch T, Vernet-Garnier V, Appriou M, Petit JS, Jovenin N, Lamiable D, Hoizey G.
    Pathol Biol (Paris); 2005 Sep; 53(8-9):546-50. PubMed ID: 16023303
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y, Jin L, Liu N, Luo X, Dong D, Tang J, Wang Y, You Y, Liu Y, Chen M, Yu Z, Hao Y, Gu Q.
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [Abstract] [Full Text] [Related]

  • 38. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J, Rodvold KA.
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [Abstract] [Full Text] [Related]

  • 39. Nosocomial pneumonia.
    Ostendorf U, Ewig S, Torres A.
    Curr Opin Infect Dis; 2006 Aug; 19(4):327-38. PubMed ID: 16804379
    [Abstract] [Full Text] [Related]

  • 40. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Akova M.
    Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.